William Blair

Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses
Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses
Why uniQure Stock Is Trading Lower After FDA Meeting Update
Why uniQure Stock Is Trading Lower After FDA Meeting Update
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Why uniQure Stock Is Trading Lower After FDA Meeting Update
Why uniQure Stock Is Trading Lower After FDA Meeting Update
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Intuitive Surgical Q3 Results Ease Bear Market Concerns, Analyst Views 'Headwinds As Largely Noise'
Intuitive Surgical Q3 Results Ease Bear Market Concerns, Analyst Views 'Headwinds As Largely Noise'
Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says
Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says

William Blair Recent News

Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
Nektar's rezpegaldesleukin met key efficacy targets in a mid-stage eczema study, though analysts flagged safety and differentiation concerns.
What's Going On With Viking Therapeutics Stock On Wednesday?
What's Going On With Viking Therapeutics Stock On Wednesday?
Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks.
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand
Sarepta shares face pressure after a second Elevidys-linked death and analyst downgrade over safety concerns and lowered revenue prospects.
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss and liver health benefits.
Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move
Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move
Pyxis Oncology prioritizes PYX-201 with promising Phase 1 results in solid tumors, while deprioritizing PYX-106 due to resource allocation and challenges.
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.
Carvana's Q4 Earnings Impress Analysts, Shares Surge On Strong Profit Outlook
Carvana's Q4 Earnings Impress Analysts, Shares Surge On Strong Profit Outlook
Shares of Carvana Co (NYSE: CVNA) were climbing in early trading on Friday, after the company reported its fourth-quarter results.
Block Re-Focuses On Cash App, 8 Analysts Provide Their Takeaways From Q4 Results
Block Re-Focuses On Cash App, 8 Analysts Provide Their Takeaways From Q4 Results
Block Inc (NYSE: SQ) Thursday reported its fourth-quarter results and issued full-year guidance.
Twilio Reports Upbeat Q4 Earnings, But Investors Pull Back: What 7 Wall Street Analysts Are Saying
Twilio Reports Upbeat Q4 Earnings, But Investors Pull Back: What 7 Wall Street Analysts Are Saying
Twilio Inc (NYSE: TWLO) shares tanked in early trading on Thursday, even after the company reported upbeat results for its fourth quarter.
Chegg AI Investments Not Translating To Improved Fundamentals, Analysts Dive Deeper Into Q4 Print
Chegg AI Investments Not Translating To Improved Fundamentals, Analysts Dive Deeper Into Q4 Print
Shares of Chegg Inc (NYSE: CHGG) slipped in early trading on Tuesday, after declining more than 8% in the premarket session.
Palantir Rallies Off AI-Driven Q4 Earnings: Bull Analyst Sees 'Off The Charts Commercial Success'
Palantir Rallies Off AI-Driven Q4 Earnings: Bull Analyst Sees 'Off The Charts Commercial Success'
Shares of Palantir Technologies Inc (NYSE: PLTR) were climbing Tuesday after the company reported better-than-expected fourth-quarter results.
Starbucks Fails To Serve Hot Results, Brewing Analyst Concerns Over China Sales, Boycott Effects
Starbucks Fails To Serve Hot Results, Brewing Analyst Concerns Over China Sales, Boycott Effects
Shares of Starbucks Corp (NASDAQ: SBUX) were trading lower on Wednesday after the company reported its first-quarter results short of expectations.
6 Netflix Analysts Size Up Earnings, Subscribers, WWE Deal: 'WWE Raw Changes The Game'
6 Netflix Analysts Size Up Earnings, Subscribers, WWE Deal: 'WWE Raw Changes The Game'
Analysts size up the WWE deal signed by Netflix and what fourth quarter results mean going forward.
Why This UiPath Analyst Believes Stock Is Still Attractive After 100% Gain In 2023
Why This UiPath Analyst Believes Stock Is Still Attractive After 100% Gain In 2023
Shares of UiPath Inc (NYSE: PATH) ended 2023 with gains of more than 100%.
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday.
MongoDB Shares Continue To Tank On Q3 Print: Why These Analysts Are Encouraged By Results
MongoDB Shares Continue To Tank On Q3 Print: Why These Analysts Are Encouraged By Results
MongoDB Inc (NASDAQ: MDB) shares tanked in early trading on Wednesday despite the company reporting upbeat third-quarter results.
Roku Shares Jump After Q3 Delivers Many Positives: 7 Analysts Tune Into Into Print, Guide
Roku Shares Jump After Q3 Delivers Many Positives: 7 Analysts Tune Into Into Print, Guide
Roku Inc (NASDAQ: ROKU) shares climbed in early trading on Thursday, after the company reported strong quarterly results.
PayPal Q3 Is 'All About' New CEO's Vision: 5 Analysts Explore Earnings, Prospects
PayPal Q3 Is 'All About' New CEO's Vision: 5 Analysts Explore Earnings, Prospects
Shares of PayPal Holdings Inc (NASDAQ: PYPL) rose in early trading on Thursday, after the company reported its third-quarter (Q3) results.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved